Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

1M2R

Crystal structure of 5,8-di-amino-1,4-di-hydroxy-anthraquinone/CK2 kinase complex

Summary for 1M2R
Entry DOI10.2210/pdb1m2r/pdb
Related1F0Q 1J91 1JAM 1M2P 1M2Q
DescriptorCASEIN kinase II, alpha chain, 5,8-DI-AMINO-1,4-DIHYDROXY-ANTHRAQUINONE (3 entities in total)
Functional Keywordskinase, inhibitor-enzyme complex, transferase
Biological sourceZea mays
Total number of polymer chains1
Total formula weight38943.63
Authors
De Moliner, E.,Moro, S.,Sarno, S.,Zagotto, G.,Zanotti, G.,Pinna, L.A.,Battistutta, R. (deposition date: 2002-06-25, release date: 2003-06-17, Last modification date: 2024-02-14)
Primary citationDe Moliner, E.,Sarno, S.,Moro, S.,Zanotti, G.,Battistutta, R.,Pinna, L.A.
Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight
J.Biol.Chem., 278:1831-1836, 2003
Cited by
PubMed Abstract: Protein kinases play key roles in signal transduction and therefore are among the most attractive targets for drug design. The pharmacological aptitude of protein kinase inhibitors is highlighted by the observation that various diseases with special reference to cancer are because of the abnormal expression/activity of individual kinases. The resolution of the three-dimensional structure of the target kinase in complex with inhibitors is often the starting point for the rational design of this kind of drugs, some of which are already in advanced clinical trial or even in clinical practice. Here we present and discuss three new crystal structures of ATP site-directed inhibitors in complex with "casein kinase-2" (CK2), a constitutively active protein kinase implicated in a variety of cellular functions and misfunctions. With the help of theoretical calculations, we disclose some key features underlying the inhibitory efficiency of anthraquinone derivatives, outlining three different binding modes into the active site. In particular, we show that a nitro group in a hydroxyanthraquinone scaffold decreases the inhibitory constants K(i) because of electron-withdrawing and resonance effects that enhance the polarization of hydroxylic substituents in paraposition.
PubMed: 12419810
DOI: 10.1074/jbc.M209367200
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.7 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon